We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Adding to this trend is the launch of the first Lantus biosimilars, a shift which raises the bar for new insulin products. Novo has not given up on the idea of an oral insulin completely ...

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...

North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for ...

County Public Schools has joined dozens of other school systems and institutions in suing pharmaceutical and pharmacy companies, alleging that the companies manipulated the prices of insulin and other ...

Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on January 13 and set a price target of ...

A bill to lower the price of insulin drugs and supplies for more North Dakotans attracted passionate discussion at a Thursday ...

Products under the program include insulin vials, pens, continuous glucose monitors and pumps by manufacturers Novo Nordisk, Eli Lilly, Sanofi, Dexcom and Insulet. About one in 10 Americans have ...